Britain's testing system for COVID-19 was creaking on Tuesday as a bottleneck prevented people including medics from getting a test in a potential threat to key health services, health sector organisations said.
LONDON - Britain’s testing system for COVID-19 was creaking on Tuesday as a bottleneck prevented people including medics from getting a test in a potential threat to key health services, health sector organisations said.
“Our members are telling us that lack of access to testing for staff is a major barrier to them delivering services,” said Layla McCay, director at the NHS Confederation, which represents organisations across the healthcare sector. Chris Hopson, chief executive of NHS Providers, which represent hospital trusts in England, said a growing number staff were unable to come to work because they or someone they live with had COVID-like symptoms but couldn’t get tested.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Valneva to supply up to 190 million doses of COVID-19 vaccine to UKFrench vaccine maker Valneva said on Monday it would supply the UK with up to 190 million doses of its coronavirus vaccine candidate, VLA2001, over a five-year period.
Read more »
Twin disasters: How the West Coast fires might impact the COVID-19 pandemicThe combination of airway inflammation caused by irritants in smoke plus underlying conditions such as asthma or chronic obstructive pulmonary disease create a 'perfect storm' for poor COVID-19 outcomes.
Read more »
Congress operations forced to change during pandemic, COVID-19 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
BioNTech wins $445 million German grant for COVID-19 vaccineGerman biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany.
Read more »